Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis

32Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Autoimmune pancreatitis (AIP), in contrast to other benign chronic pancreatic diseases, can be cured with immunosuppressant drugs, thus the differentiation of AIP from pancreatic cancer is of particular interest in clinical practice. There is the possibility that some patients with AIP may develop pancreatic cancer, and this possibility contributes to increasing our difficulties in differentiating AIP from pancreatic cancer. We herein report the case of a 70-year-old man in whom pancreatic adenocarcinoma and AIP were detected simultaneously. We must carefully monitor AIP patients for the simultaneous presence of pancreatic cancer, even when a diagnosis of AIP is confirmed. Copyright © 2011 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Pezzilli, R., Vecchiarelli, S., Di Marco, M. C., Serra, C., Santini, D., Calculli, L., … Imbrogno, A. (2011). Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. Case Reports in Gastroenterology, 5(2), 378–385. https://doi.org/10.1159/000330291

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free